Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Editas Medicine (EDIT) Amortizatization of Intangibles: 2021-2024

Historic Amortizatization of Intangibles for Editas Medicine (EDIT) over the last 4 years, with Dec 2024 value amounting to $5.8 million.

  • Editas Medicine's Amortizatization of Intangibles fell 95.32% to $62,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.8 million, marking a year-over-year decrease of 74.79%. This contributed to the annual value of $5.8 million for FY2024, which is 20.07% up from last year.
  • As of FY2024, Editas Medicine's Amortizatization of Intangibles stood at $5.8 million, which was up 20.07% from $4.8 million recorded in FY2023.
  • Editas Medicine's Amortizatization of Intangibles' 5-year high stood at $5.8 million during FY2024, with a 5-year trough of -$1.7 million in FY2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $4.8 million (2023), whereas its average is $3.8 million.
  • Data for Editas Medicine's Amortizatization of Intangibles shows a peak YoY surged of 566.16% (in 2023) over the last 5 years.
  • Yearly analysis of 4 years shows Editas Medicine's Amortizatization of Intangibles stood at -$1.7 million in 2021, then skyrocketed by 143.69% to $724,000 in 2022, then skyrocketed by 566.16% to $4.8 million in 2023, then increased by 20.07% to $5.8 million in 2024.